Research about the influence of alprostadil for the renal blood flow parameters and fibrosis indexes of patients with diabetic nephropathy

Research about the influence of alprostadil for the renal blood flow parameters and fibrosis indexes of patients with diabetic nephropathy

Objective: To observe the curative effects of alprostadil on diabetes nephropathy and its influences on the renal blood flow parameters and fibrosis indexes of patients. Methods: Eighty cases of patients with diabetic nephropathy who were treated in our hospital from May 2013 to September 2014 we...

Full description

Bibliographic Details
Main Authors:	Li Ling, Guo-Juan Lao, Li-Bo Chen, Diao-Zhu Lin
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2016-01-01
Series:	Journal of Hainan Medical University
Subjects:	Diabetic nephropathy Alprostadil Renal blood flow Fibrosis
Online Access:	http://www.hnykdxxb.com/PDF/201602/14.pdf

Similar Items

Effect of alprostadil combined with fosinopril therapy on renal function and oxidative stress in patients with diabetic nephropathy
by: Wei Wang, et al.
Published: (2016-08-01)

Effects of injection Shenkang and alprostadil combination on contrast-induced nephropathy in patient with diabetes complicated with mild to moderate renal insufficiency
by: Yanfang Zhang, et al.
Published: (2017-08-01)

Assessment of renal function and oxidative stress after alprostadil combined with valsartan treatment of early diabetic nephropathy
by: Jun Tang, et al.
Published: (2017-05-01)

Assessment of the renal function, peroxidation damage and inflammatory injury after epalrestat combined with alprostadil treatment of early diabetic nephropathy
by: Hai-Xia Li, et al.
Published: (2017-05-01)

Clinical effect of Calcium Dobesilate combinated with Alprostadil in the vascular endothelium of patients with diabetic nephropathy
by: Qing-Mei Wang, et al.
Published: (2019-05-01)

Effect of alprostadil on hemorheology, immune function, MDA, SOD and ROS in patients with diabetic nephropathy
by: Li-Li Xia, et al.
Published: (2015-07-01)

Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
by: Hong Yan, et al.
Published: (2017-10-01)

Therapeutic Effect of Alprostadil in Diabetic Nephropathy: Possible Roles of Angiopoietin-2 and IL-18
by: Changqing Luo, et al.
Published: (2014-08-01)

Effects of alprostadil combined with Bailing Capsule on residual renal function, renal hemodynamics, immune indexes and nutritional status in patients with chronic renal failure
by: Sheng Wan
Published: (2020-04-01)

Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil
by: Seung Mook Jung
Published: (2019-03-01)

Effects of alprostadil on respiratory parameters and hemodynamics of newborns with persistent pulmonary hypertension
by: Lan Zhang, et al.
Published: (2017-10-01)

Effects of alprostadil combined with nucleoside antiviral drugs on liver function, liver fibrosis markers and serum inflammatory factors in patients with decompensated liver cirrhosis with HBV infection
by: Jing-Chun Song, et al.
Published: (2019-04-01)

Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia–reperfusion injury in rats
by: Erer D, et al.
Published: (2016-08-01)

Effect of alprostadil combined with Shenkang injection on urine protein, renal function and serum inflammatory in patients with chronic nephritis
by: Chen Wang, et al.
Published: (2016-10-01)

The protective effect of Papaverine and Alprostadil in rat testes after ischemia and reperfusion injury
by: Mehmet Ali Karagoz, et al.

Alprostadil plus Vacuum (VITARUM) in severe erectile dysfunction (ED)
by: Franco Mantovani
Published: (2017-06-01)

Clinical observation of alprostadil combined with glucocorticoids on acute optic neuritis
by: Ke-Shun Fan, et al.
Published: (2015-09-01)

Efficacy of entecavir combined with alprostadil in treatment of hepatitis B-related cirrhotic ascites
by: LI Huili, et al.
Published: (2016-02-01)

Effect of alprostadil combined with conventional therapy on serum markers in patients with acute cerebral infarction
by: Li-Lan Chen, et al.
Published: (2016-01-01)

Effects of Compound α-Ketoacid Tablets on renal function, renal fibrosis indexes and oxidative stress in patients with diabetic nephropathy
by: Hai-Yun Dong, et al.
Published: (2018-09-01)

How effective are alprostadil and hydrocortisone on reperfusion injury in kidney after distant organ ischemia?
by: Ali Ebrahimi, et al.
Published: (2013-01-01)

Effect of atorvastatin on renal fibrosis, oxidative stress and related factors in patients with diabetic nephropathy
by: Xiu Hu, et al.
Published: (2019-05-01)

Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
by: M. P. Graham-Brown, et al.
Published: (2019-07-01)

Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy
by: Jing Pan, et al.
Published: (2019-01-01)

Psoralea corylifolia L. Seed Extract Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis and Apoptosis in Streptozotocin-Induced Diabetic Mice
by: Eunhui Seo, et al.
Published: (2017-08-01)

Effect of alprostadil combined with butylphthalide on the serum inflammatory factors and coagulable function in patients with acute ischemic stroke
by: Wen-Zhuo Dai, et al.
Published: (2016-06-01)

Is It Worth Continuing Sexual Rehabilitation after Radical Prostatectomy with Intracavernous Injection of Alprostadil for More than 1 Year?
by: René Yiou, MD, PhD, PUPH, et al.
Published: (2015-03-01)

Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy
by: Changwei Wu, et al.
Published: (2018-12-01)

The effect of alprostadil on perihematomal tissue of experimental intracerebral hemorrhage in rats
by: Juan CHENG, et al.
Published: (2011-06-01)

Calreticulin is important for the development of renal fibrosis and dysfunction in diabetic nephropathy
by: Ailing Lu, et al.
Published: (2020-11-01)

Effects of alprostadil combined with lipoic acid on clinical efficacy, hemodynamics, fibronectin and plasma D-dimer in elderly patients with type 2 diabetic foot
by: Yong-Yi Shan
Published: (2020-11-01)

Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
by: Priscila Calle, et al.
Published: (2020-04-01)

Protective Effects of N-acetylcysteine and a Prostaglandin E1 Analog, Alprostadil, Against Hepatic Ischemia: Reperfusion Injury in Rats
by: Cheng-Chu Hsieh, et al.
Published: (2014-01-01)

Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin
by: Xiao-peng Zheng, et al.
Published: (2020-05-01)

ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
by: Yu-Li Shen, et al.
Published: (2020-01-01)

Correction of Kidney Blood Circulation in Patients with Purulent Pyelonephritis
by: V. A. Ananev, et al.
Published: (2019-03-01)

Serum Matrix Metalloproteinase-7 Level is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy
by: Jian Zhang, et al.
Published: (2017-09-01)

FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation
by: Xiaomin Zhang, et al.
Published: (2018-05-01)

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
by: Shan Shan Qi, et al.
Published: (2020-03-01)

Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis
by: Weiping Xia, et al.
Published: (2021-07-01)